1. Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy

Volume 23, Issue 3, March 2022, Pages 1053-1059

Ahmad Aizat Abdul Aziz; Md Salzihan Md Salleh; Maya Mazuwin Yahya; Andee Dzulkarnaen Zakaria; Ravindran Ankathil

• View Article
• PDF 389.62 K

2. Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC

Volume 23, Issue 1, January 2022, Pages 241-251

Mila Hanifa; Raditya Wulandari; Ummi Maryam Zulfin; Eri Prasetyo Nugroho; Sari Haryanti; Edy Meiyanto

• View Article
• PDF 1.58 MB

3. Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468

Volume 22, Issue 7, July 2021, Pages 2079-2087

Maryam Ashourpour; Fatemeh Mostafavi Hosseini; Mohsen Amini; Ebrahim Saeedian Moghadam; Faranak Kazerouni; Seyed Yousef Arman; Zahra Shahsavari

• View Article
• PDF 562.6 K

4. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells

Volume 22, Issue 7, July 2021, Pages 2177-2184

Akanksha Kashyap; Sheikh Mohammad Umar; Arundhathi Dev J R; Chandra Prakash Prasad

• View Article
• PDF 745.48 K

5. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen

Volume 22, Issue 4, April 2021, Pages 1319-1324

Ahmad Aizat Abdul Aziz; Md Salzihan Md Salleh; Maya Mazuwin Yahya; Andee Dzulkarnaen Zakaria; Ravindran Ankathil

• View Article
• PDF 389.56 K

6. A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer

Volume 21, Issue 3, March 2020, Pages 749-754

Bader A Abdelmaksoud; Abdelmotaleb Mohammed; Mostafa M Toam

• View Article
• PDF 295.77 K

7. Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)

Volume 19, Issue 12, December 2018, Pages 3581-3589

Mahitab Ibrahim Eltohamy; Omnia Mohammed Badawy; Naglaa El kinaai; Iman Loay; Hanan Ramadan Nassar; Rasha Mahmoud Allam; Mona Ali Sakr

• View Article
• PDF 2.34 MB

8. Clinicopathology Figures and Long-term Effects of Tamoxifen Plus Radiation on Survival of Women with Invasive Ductal Carcinoma and Triple Negative Breast Cancer

Volume 16, Issue 12, December 2015, Pages 4863-4867

• View Article
• PDF 796.79 K

9. Ultrasonographic Features of Triple-Negative Breast Cancer: a Comparison with Other Breast Cancer Subtypes

Volume 16, Issue 8, August 2015, Pages 3229-3232

• View Article
• PDF 383.84 K

10. Increased Hypermethylation of Glutathione S-Transferase P1, DNA-Binding Protein Inhibitor, Death Associated Protein Kinase and Paired Box Protein-5 Genes in Triple-Negative Breast Cancer Saudi Females

Volume 16, Issue 2, February 2015, Pages 541-549

• View Article
• PDF 631.31 K

11. Elevated Serum Haptoglobin is Associated with Clinical Outcome in Triple-Negative Breast Cancer Patients

Volume 13, Issue 9, September 2012, Pages 4541-4544

• View Article
• PDF 495.46 K